CD4 and COVID-19: In particular, through the use of HLA class I and II predicted peptides, “mega pools” circulating SARS-CoV-2-specific CD8+ and CD4+ T lymphocytes have respectively been found in 70% and 100% of COVID-19 convalescent individuals.